Activity of doripenem with and without levofloxacin, amikacin, and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.
about
Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula.The transcriptomic response of Acinetobacter baumannii to colistin and doripenem alone and in combination in an in vitro pharmacokinetics/pharmacodynamics model.Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic model.Optimizing Polymyxin Combinations Against Resistant Gram-Negative BacteriaIn Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.Polymyxin combinations: pharmacokinetics and pharmacodynamics for rationale use.Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance.Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenemsAntibacterial activity of human simulated epithelial lining fluid concentrations of amikacin inhale alone and in combination with meropenem against Acinetobacter baumannii.Aminoglycosides: An Overview.Recent advances and perspectives in the design and development of polymyxins.Assessment of the combination of doripenem plus a fluoroquinolone against non-susceptible Acinetobacter baumannii isolates from nosocomial pneumonia patients.Antibiotic resistance of pathogenic Acinetobacter species and emerging combination therapy.Synergistic Killing of Polymyxin B in Combination With the Antineoplastic Drug Mitotane Against Polymyxin-Susceptible and -Resistant Acinetobacter baumannii: A Metabolomic Study.
P2860
Q35364351-A640E3EF-24AF-41B6-A275-648871F53B53Q35432662-F50BBC08-9B4D-4BC1-A020-254A37D43E90Q35598403-CBF35637-DDFF-4453-9916-EAC949929916Q36363261-D4F4551E-E3D4-4A7D-BD0C-D57A91AAFDA2Q36465442-D1F94C7B-E3DC-4101-8FEB-8F39FC7FFF3BQ37562099-187CECB5-DE0A-42FA-BCFB-D7BF761ACE56Q37869910-5C071DD2-1F85-4C26-AE1C-5DFFEE234791Q38126768-20FA58C1-907C-4EAB-9E37-F5ED16150708Q38652103-D7698356-292C-4CF6-ACEF-4ED92E9B2C26Q38851189-CDA8B11F-D72B-4713-9294-665BD2288772Q39190865-7F4F8C6B-4007-425B-93ED-4F419D12FC02Q44064611-FEEC0424-8246-42F1-A12A-B2CF916E5853Q46273551-080B7A32-8731-46DC-894D-56CF20084E85Q53689690-184C9395-B4C5-4500-B495-EFF3CD28236A
P2860
Activity of doripenem with and without levofloxacin, amikacin, and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Activity of doripenem with and ...... a and Acinetobacter baumannii.
@en
Activity of doripenem with and ...... a and Acinetobacter baumannii.
@nl
type
label
Activity of doripenem with and ...... a and Acinetobacter baumannii.
@en
Activity of doripenem with and ...... a and Acinetobacter baumannii.
@nl
prefLabel
Activity of doripenem with and ...... a and Acinetobacter baumannii.
@en
Activity of doripenem with and ...... a and Acinetobacter baumannii.
@nl
P2093
P1476
Activity of doripenem with and ...... a and Acinetobacter baumannii.
@en
P2093
Glenn A Pankuch
Harald Seifert
Peter C Appelbaum
P304
P356
10.1016/J.DIAGMICROBIO.2010.01.004
P577
2010-03-24T00:00:00Z